Larry Robbins's ELV Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 66,599 shares of Elevance Health, Inc. (ELV) worth $25.76 M, representing 0.47% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 35 quarters.
Based on 13F filings, Larry Robbins has maintained a strategic position in ELV, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2016, adding 1.64 M shares. Largest reduction occurred in Q1 2017, reducing 1.16 M shares.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Larry Robbins
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +66,599 | New Buy | 66,599 | $386.73 |
| Q3 2024 | -98,578 | Sold Out | 0 | $0.00 |
| Q2 2024 | -75,651 | Reduce 43.42% | 98,578 | $541.86 |
| Q1 2024 | +136,320 | Add 359.60% | 174,229 | $518.54 |
| Q4 2023 | +22,982 | Add 153.96% | 37,909 | $471.56 |
| Q3 2023 | +14,927 | New Buy | 14,927 | $435.42 |
| Q2 2023 | -11,867 | Sold Out | 0 | $0.00 |
| Q1 2023 | +11,867 | New Buy | 11,867 | $459.81 |
| Q4 2021 | -88,011 | Sold Out | 0 | $0.00 |
| Q3 2021 | -84,702 | Reduce 49.04% | 88,011 | $372.81 |
| Q2 2021 | -90,920 | Reduce 34.49% | 172,713 | $381.80 |
| Q1 2021 | +79,172 | Add 42.92% | 263,633 | $358.95 |
| Q4 2020 | +184,461 | New Buy | 184,461 | $321.09 |
| Q1 2020 | -751,142 | Sold Out | 0 | $0.00 |
| Q4 2019 | -116,885 | Reduce 13.47% | 751,142 | $302.03 |
| Q3 2019 | -2,790 | Reduce 0.32% | 868,027 | $240.10 |
| Q2 2019 | -147,420 | Reduce 14.48% | 870,817 | $282.21 |
| Q1 2019 | +145,804 | Add 16.71% | 1.02 M | $286.98 |
| Q4 2018 | -414,516 | Reduce 32.21% | 872,433 | $262.63 |
| Q3 2018 | +11,287 | Add 0.88% | 1.29 M | $274.05 |
| Q2 2018 | -1.01 M | Reduce 44.08% | 1.28 M | $238.03 |
| Q1 2018 | -776,162 | Reduce 25.39% | 2.28 M | $219.70 |
| Q4 2017 | -745,018 | Reduce 19.59% | 3.06 M | $225.01 |
| Q3 2017 | -248,116 | Reduce 6.13% | 3.8 M | $189.88 |
| Q2 2017 | -661,014 | Reduce 14.03% | 4.05 M | $188.13 |
| Q1 2017 | -1.16 M | Reduce 19.79% | 4.71 M | $165.38 |
| Q4 2016 | +276,807 | Add 4.95% | 5.87 M | $143.77 |
| Q3 2016 | +1.64 M | Add 41.37% | 5.6 M | $125.31 |
| Q2 2016 | +314,600 | Add 8.63% | 3.96 M | $131.34 |
| Q1 2016 | -659,249 | Reduce 15.32% | 3.64 M | $138.99 |
| Q4 2015 | +53,664 | Add 1.26% | 4.3 M | $139.44 |
| Q3 2015 | -369,265 | Reduce 7.99% | 4.25 M | $140.00 |
| Q2 2015 | -273,934 | Reduce 5.60% | 4.62 M | $164.14 |
| Q1 2015 | +1.3 M | Add 36.21% | 4.89 M | $154.41 |
| Q4 2014 | +3.59 M | New Buy | 3.59 M | $125.67 |
Larry Robbins's Elevance Health Investment FAQs
Larry Robbins first purchased Elevance Health, Inc. (ELV) in Q4 2014, acquiring 3,592,645 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held Elevance Health, Inc. (ELV) for 35 quarters since Q4 2014.
Larry Robbins's largest addition to Elevance Health, Inc. (ELV) was in Q4 2014, adding 3,592,645 shares worth $451.49 M.
According to the latest 13F filing for Q2 2026, Larry Robbins's firm, Glenview Capital Management, LLC, owns 66,599 shares of Elevance Health, Inc. (ELV), valued at approximately $25.76 M.
As of the Q2 2026 filing, Elevance Health, Inc. (ELV) represents approximately 0.47% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.
Larry Robbins's peak holding in Elevance Health, Inc. (ELV) was 5,874,049 shares, as reported at the end of Q4 2016.